Literature DB >> 26098953

Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients.

A Kruchen1,2, T Stahl3, F Gieseke1, T M C Binder4, Z Özcan5, R Meisel5, H Kreyenberg6, P Bader6, B Gruhn7, J Greil8, M Pfeiffer9, M Döring9, R Handgretinger9, B Fehse3, I Müller1,2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26098953     DOI： 10.1038/bmt.2015.136

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  20 in total

Review 1.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

2.  Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction.

Authors:  Mehdi Alizadeh; Marc Bernard; Bruno Danic; Charly Dauriac; Brigitte Birebent; Christine Lapart; Thierry Lamy; Pierre-Yves Le Prisé; Alain Beauplet; Dominique Bories; Gilbert Semana; Erwann Quelvennec
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

Review 3.  Haploidentical hematopoietic transplantation: current status and future perspectives.

Authors:  Yair Reisner; David Hagin; Massimo F Martelli
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

4.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Authors:  Jeffrey M Venstrom; Gianfranco Pittari; Ted A Gooley; Joseph H Chewning; Stephen Spellman; Michael Haagenson; Meighan M Gallagher; Mari Malkki; Effie Petersdorf; Bo Dupont; Katharine C Hsu
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

5.  Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

Authors:  Jon J van Rood; Fausto R Loberiza; Mei-Jie Zhang; Machteld Oudshoorn; Frans Claas; Mitchell S Cairo; Richard E Champlin; Robert Peter Gale; Olle Ringdén; Jill M Hows; Mary H Horowitz
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

6.  Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

Authors:  Jeffery S Miller; Sarah Cooley; Peter Parham; Sherif S Farag; Michael R Verneris; Karina L McQueen; Lisbeth A Guethlein; Elizabeth A Trachtenberg; Michael Haagenson; Mary M Horowitz; John P Klein; Daniel J Weisdorf
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

7.  NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.

Authors:  Loredana Ruggeri; Antonella Mancusi; Emanuela Burchielli; Marusca Capanni; Alessandra Carotti; Teresa Aloisi; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Blood Cells Mol Dis       Date:  2007-10-26       Impact factor: 3.039

8.  Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.

Authors:  Martin Stern; Loredana Ruggeri; Antonella Mancusi; Maria Ester Bernardo; Claudia de Angelis; Christoph Bucher; Franco Locatelli; Franco Aversa; Andrea Velardi
Journal:  Blood       Date:  2008-05-20       Impact factor: 22.113

9.  Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.

Authors:  D W Bianchi; G K Zickwolf; G J Weil; S Sylvester; M A DeMaria
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

10.  Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group.

Authors:  Thomas Klingebiel; Jacqueline Cornish; Myriam Labopin; Franco Locatelli; Philippe Darbyshire; Rupert Handgretinger; Adriana Balduzzi; Joanna Owoc-Lempach; Franca Fagioli; Reuven Or; Christina Peters; Franco Aversa; Emmanuelle Polge; Giorgio Dini; Vanderson Rocha
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113
View more
  3 in total

1.  Immunologic benefits of maternal living donor allografts in pediatric liver transplantation: fewer rejection episodes and no evidence of de novo allosensitization.

Authors:  Arianna Barbetta; Glenda Meeberg; Brittany Rocque; Sarah Barhouma; Carly Weaver; Susan Gilmour; Farah Faytrouni; Orlee Guttman; Shannon Zielsdorf; Kambiz Etesami; Yong Kwon; George Yanni; Patricia Campbell; James Shapiro; Juliet Emamaullee
Journal:  Pediatr Transplant       Date:  2021-11-21

2.  Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia.

Authors:  Jingbo Wang; Lei Yuan; Haoyu Cheng; Xinhong Fei; Yumin Yin; Jiangying Gu; Song Xue; Junbao He; Fan Yang; Xiaocan Wang; Yixin Yang; Weijie Zhang
Journal:  Oncotarget       Date:  2017-12-01

3.  Influence of Fetomaternal Microchimerism on Maternal NK Cell Reactivity against the Child's Leukemic Blasts.

Authors:  Lena-Marie Martin; Anne Kruchen; Boris Fehse; Ingo Müller
Journal:  Biomedicines       Date:  2022-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.